Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost

Safety and IOP Lowering Efficacy of Low Dose Travoprost Ophthalmic Solutions Dosed BID Compared to TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension

The purpose of this study is to compare the safety and IOP-lowering efficacy of various low dose travoprost formulations in patients with open-angle glaucoma or ocular hypertension.

Inclusion Criteria:

• Patients 18 years of age or older, either sex or race with open-angle glaucoma or confirmed ocular hypertension
• Other protocol-defined inclusion criteria may apply

Exclusion Criteria:

• Age related
• Other protocol-defined exclusion criteria may apply